Journal of Obstetrics and Gynecology of India最新文献

{"title":"Comparison of Feto-maternal Outcomes Among Various BMI Groups As Per Asia Pacific Standards: An Observational Retrospective Comparative Study in a Private Tertiary Care Center in Delhi.","authors":"Arpita De, Aruna Nigam, Sumedha Sharma, Arifa Anwar","doi":"10.1007/s13224-022-01739-3","DOIUrl":"10.1007/s13224-022-01739-3","url":null,"abstract":"<p><strong>Objective: </strong>To compare the feto-maternal outcomes among various BMI groups as per Asia Pacific Standards.</p><p><strong>Method: </strong>This is a retrospective non-interventional observational study on 1396 antenatal women with singleton pregnancy. Their BMI based on pre-pregnancy weight was calculated and the women were divided into various groups as per Asia Pacific standards for BMI classification. Details of associated morbidities and delivery outcomes were noted in a pre-structured proforma and a comparison was made among the various groups using Chi square test. A <i>p</i> value of < 0.05 was taken as significant.</p><p><strong>Results: </strong>Among the 1396 women under study, 10.6% were underweight, 36% had normal weight, 21% were overweight while 32% were obese or very obese. There was a significant association of low BMI with preterm labor (<i>p</i> value 0.03) and fetal growth restriction (<i>p</i> value < 0.01). Overweight and obese women were found to be more prone to hypertensive disorders of pregnancy (<i>p</i> value- 0.002), gestational diabetes (<i>p</i> value- 0.003) and overweight women were more prone to cholestasis of pregnancy (<i>p</i> value 0.03). The women with higher BMI had a significantly higher requirement of induction of labor (<i>p</i> value-0.0002). There was significant increased number of babies more than 90th percentile in overweight and obese women (<i>p</i> value 0.003). However, there was no change in Neonatal ICU admissions (<i>p</i> value 0.85) or neonatal mortality.</p><p><strong>Conclusion: </strong>Asia Pacific references should be used for studies related to all studies on BMI and pregnancy. All women having BMI outside the normal BMI spectrum are at increased risk of antenatal and postnatal complications. Early identification of such women will enable careful evaluation and counseling to improve the reproductive outcome and feto-maternal health.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"73 3","pages":"223-228"},"PeriodicalIF":0.7,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267023/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9653952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An Unusual Presentation of Gastrointestinal Stromal Tumor as an Ovarian Mass: A Diagnostic Dilemma.","authors":"Jyoti Baghel, Hema Pant, Amit Kumar Singh, Rajneesh Rawat","doi":"10.1007/s13224-023-01743-1","DOIUrl":"10.1007/s13224-023-01743-1","url":null,"abstract":"","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"73 3","pages":"282-284"},"PeriodicalIF":0.7,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267039/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9659996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Can Medical Nutrition Therapy Affect Feto-Maternal Outcomes in Gestational Glucose Intolerance: An Open-Label Pilot Randomized Control Trial in World's Diabetes Capital.","authors":"Namrata Kumar, Vinita Das, Anveshika Srivastava, Anjoo Agarwal, Amita Pandey, Smriti Agarwal","doi":"10.1007/s13224-022-01722-y","DOIUrl":"10.1007/s13224-022-01722-y","url":null,"abstract":"<p><strong>Introduction: </strong>Gestational diabetes is defined as the carbohydrate intolerance of variable severity with onset or first recognition during pregnancy. Gestational glucose intolerance (GGI) is used to indicate pregnant women whose 2-h postprandial glucose is > 120 mg/dl and below 140 mg/dl (Diabetes in Pregnancy Study Group of India, DIPSI criteria).</p><p><strong>Aim: </strong>This study was planned to see whether intervention in GGI group helps to improve feto-maternal outcomes.</p><p><strong>Methodology: </strong>This open-label randomized control trial was conducted in Department of Obstetrics and Gynaecology of King George's Medical University, Lucknow. Inclusion criteria were all the antenatal women attending the antenatal clinic and diagnosed as GGI, and exclusion criteria were overt diabetes.</p><p><strong>Results: </strong>Total of 1866 antenatal women were screened, and among them, 220 (11.8%) women were diagnosed as gestational diabetes; 412 (22.1%) women were diagnosed as GGI. The mean fasting blood sugars in the women with GGI who had medical nutrition therapy were much lower than the women with GGI who did not have any intervention. The present study showed the women with GGI had higher complications like polyhydramnios, PPROM, foetal growth restriction, macrosomia, preeclampsia, preterm labour and vaginal candidiasis more in the women with GGI as compared to euglycaemic women.</p><p><strong>Conclusion: </strong>The present study of nutritional intervention in GGI group has shown trend towards lesser complication if we start medical nutrition therapy reflected by delayed development of GDM and less neonatal hypoglycaemia and hyperbilirubinemia.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"73 3","pages":"208-213"},"PeriodicalIF":0.7,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267021/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10301148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Postpartum Collapse Subsequent to Catatonia in a Female with COVID-19 Infection: a Rare Entity Visited.","authors":"Bharti Joshi,&nbsp;Swapnajeet Sahoo,&nbsp;G R V Prasad,&nbsp;Vanita Suri,&nbsp;Varun Mahajan,&nbsp;Sandeep Grover,&nbsp;Rinne Brar,&nbsp;Seema Chopra","doi":"10.1007/s13224-022-01737-5","DOIUrl":"10.1007/s13224-022-01737-5","url":null,"abstract":"<p><p>Postpartum collapse is a life-threatening condition caused by obstetrical and non-obstetrical events. In this case report, we discuss a case of postpartum collapse in COVID-19-positive woman who required intensive care and mechanical ventilation for two days. After confusing collision of many provisional diagnoses soldiering for three days, she was ultimately diagnosed with malignant catatonia. Targeted therapy with lorazepam challenge resulted in drastic improvement, and she was discharged with her baby in healthy condition.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"73 3","pages":"279-281"},"PeriodicalIF":0.7,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838526/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10038077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Prospective Multi-centric Study of Acceptance, Insertion and Follow-Up of Postpartum Insertions of IUCD.","authors":"Shobha N Gudi,&nbsp;Jyoti Sachdeva,&nbsp;Renu Manchanda,&nbsp;Mrinalini Mani,&nbsp;Shailja Rani Ranjan Sinha,&nbsp;Sushma Sinha,&nbsp;Poonam Shivkumar,&nbsp;Reena J Wani,&nbsp;Nishi Garg,&nbsp;Sanjivani Wanjari,&nbsp;Bharati Sharma,&nbsp;Pramila Yadav,&nbsp;Neha Gangane","doi":"10.1007/s13224-022-01738-4","DOIUrl":"10.1007/s13224-022-01738-4","url":null,"abstract":"<p><strong>Purpose of the study: </strong>The unmet need for contraception in the postpartum period is a major challenge in our country. Unintended pregnancies are highest in the first year after birth, and postpartum IUCD insertion is an effective way to counter this problem. This study was planned to build up data for acceptance and follow-up of postpartum IUCD insertions.</p><p><strong>Methods: </strong>The present study has included data of PPIUCD insertions and follow-up from seven institutions over a period of 6 months. The case recruitment lasted for 3 months, including only those who had PPIUCD insertions in this period, and they were followed up for a period of 6 months. The follow-up of patients was at 6 weeks and 6 months. All issues were addressed including side effects, expulsions, myths surrounding the device, etc., along with routine postnatal care.</p><p><strong>Results and conclusion: </strong>There were 5227 deliveries and 1895 insertions. The acceptance rate was 36%, and a follow-up at 6 weeks and 6 months showed up an expulsion rate of approximately 4% and a removal rate of 5%. Overall, at the end of 6 months we have a continuation rate of 90%. This shows that a dedicated approach to postpartum contraception will definitely bring down incidence of unintended pregnancies.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"73 3","pages":"254-261"},"PeriodicalIF":0.7,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893971/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9647543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical Outcome in Patient Undergoing LSCS via ERAS Pathway versus Traditional Pathway: A Prospective Observational Study.","authors":"Bhamini Jakhetiya, Paulomi Chavda Dhakre, Divya Chaudhary, Arun Gupta","doi":"10.1007/s13224-022-01732-w","DOIUrl":"10.1007/s13224-022-01732-w","url":null,"abstract":"<p><strong>Introduction: </strong>ERAS is an evidence-based management protocol for perioperative care, to accelerate patient recovery. The field of obstetrics has been a late adapter of ERAS pathway for CS, and the literature is limited from Indian population.</p><p><strong>Material and methods: </strong>This prospective non-randomized comparative clinical study was conducted on 190 pregnant patients, out of which 95 were subjected to ERAS protocol (Group 1) and remaining 95 cases were enrolled in existing traditional protocol (Group 2). The primary objective was to compare quality of recovery based on obstetric-specific QoR 11 questionnaire between patients undergoing ERAC and traditional protocol for elective LSCS. Secondary objective was to compare perioperative bleeding, breast feeding initiation and difficulties, first oral intake, ambulation attempts, decatheterization, surgical site infection and length of hospital stay.</p><p><strong>Results: </strong>At 24 h postoperatively, mean QoR score was significantly higher for patients in the ERAC group (85.5 ± 7.46 vs 57.1 ± 11.33, <i>p</i> value < 0.01). In the ERAC group, 50.5% of the mothers started breastfeeding within first hour. The mean duration to start oral intake postoperatively was significantly lower in ERAC group. In the ERAC group, ambulation and decatheterization were attempted within 6 h postoperatively in 86.3%. The mean length of hospital stay was significantly lower for patients in the ERAC group (68.8 ± 1.9 vs 105.4 ± 25.7 h, <i>p</i> value < 0.001).</p><p><strong>Conclusion: </strong>The use of ERAC protocol at cesarean delivery significantly improves quality of recovery and length of hospital stay.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"73 3","pages":"214-222"},"PeriodicalIF":0.7,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267063/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9660001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effectiveness of Tibolone in Relieving Postmenopausal Symptoms for a Short-Term Period in Indian Women.","authors":"Renuka Malik, P Meghana Reddy","doi":"10.1007/s13224-022-01727-7","DOIUrl":"10.1007/s13224-022-01727-7","url":null,"abstract":"<p><strong>Background: </strong>Tibolone is an alternative to conventional estrogen and progesterone in relieving post-menopausal symptoms in Indian women.</p><p><strong>Material and methods: </strong>A prospective short-term observational study was done at a tertiary care teaching hospital in New Delhi from November 2019 to September 2021. Fifty-three women, less than 60 years of age, presenting with moderate to severe intensity of menopausal symptoms as assessed by measuring menopausal rating score (MRS > 8) were enrolled and given Tibolone 2.5 mg daily for 3 months. Improvements in symptoms were seen at 1 month and 3 months. Side effects were also noted.</p><p><strong>Results: </strong>Marked improvement was seen as reduction in scores of psychological, somatic and genitourinary symptoms was noted. The psychological symptoms reduced from 8.92 ± 1.959 to 2.905 ± 1.042, the somatic symptoms decreased from 8.33 ± 2.299 to 3.4 ± 1.167, and genitourinary symptoms decreased from 3.64 ± 1.42 to 2.150 ± 0.948 after 3 months of treatment with Tibolone. Only 3 patients (5.6%) experienced vaginal spotting with no major side effects.</p><p><strong>Conclusions: </strong>Tibolone is a highly effective and well accepted drug to reduce moderate to severe menopausal symptoms, especially psychological symptoms including depression.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"73 3","pages":"242-247"},"PeriodicalIF":0.7,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741860/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9701270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dermoscopy and Light Microscopy as an Aid to the Diagnosis of the Most Common Genital Parasitoses.","authors":"C Fidanzi, A Janowska","doi":"10.1007/s13224-022-01725-9","DOIUrl":"10.1007/s13224-022-01725-9","url":null,"abstract":"","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"73 3","pages":"290-291"},"PeriodicalIF":0.7,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267071/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9653955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Thrombosed Arteriovenous Malformation of Umbilical Cord.","authors":"Gianluca Raffaello Damiani, Francesca Arezzo, Antonella Vimercati, Gregorio Del Boca, Anna Biffi, Maria Gaetani, Ettore Cicinelli","doi":"10.1007/s13224-022-01635-w","DOIUrl":"10.1007/s13224-022-01635-w","url":null,"abstract":"<p><strong>Background: </strong>Arteriovenous malformation of umbilical cord is an extremely rare congenital malformation. Causes of this condition are unknown. AVM of umbilical cord can cause significant complications in the developing fetus.</p><p><strong>Methods: </strong>We report our management of the case with accurate ultrasound study that could improve and facilitate the approach to this pathology due to the lack of literature and with an overview of the available literature.</p><p><strong>Results: </strong>There are only two cases of umbilical AVM diagnosed in the prenatal period with associated pathology. The mainstay of prenatal detection is the accurate study of umbilical cord also even if it is not requested from the actual guide lines in a way to improve the perinatal morbidity and mortality.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"73 3","pages":"287-289"},"PeriodicalIF":0.7,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267090/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9653957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"National Medical Council: Important Information for the Clinician.","authors":"Geetha Balsarkar","doi":"10.1007/s13224-023-01771-x","DOIUrl":"10.1007/s13224-023-01771-x","url":null,"abstract":"","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"73 3","pages":"195-197"},"PeriodicalIF":0.7,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267015/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9660000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}